Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
60 studies found for:    Bladder AND Northwestern
Show Display Options
Rank Status Study
1 Recruiting Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer
Conditions: Recurrent Bladder Carcinoma;   Stage 0a Bladder Urothelial Carcinoma;   Stage 0is Bladder Urothelial Carcinoma;   Stage I Bladder Cancer
Interventions: Biological: BCG Solution;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Other: Pharmacological Study
2 Recruiting Microbiomes of Pelvic Pain
Conditions: Interstitial Cystitis;   Chronic Prostatitis;   Chronic Pelvic Pain Syndrome;   Lower Urinary Tract Symptoms;   Overactive Bladder;   Major Depression
3 Recruiting The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence
Conditions: Mixed Urinary Incontinence;   Stress Urinary Incontinence;   Urgency Incontinence
Interventions: Drug: OnabotulinumtoxinA (Botox ®) Injections;   Drug: Saline Injections
4 Recruiting Sacral Neuromodulation and the Microbiome
Condition: Urgency Urinary Incontinence
Intervention: Device: InterStim Therapy
5 Recruiting Sacral Neuromodulation in Dual Incontinence: Ultrasound and Afferent Nerve Sensation Assessment
Conditions: Dual Incontinence;   Fecal Incontinence;   Urinary Incontinence;   Sacral Neuromodulation
Intervention: Device: Neurometer
6 Active, not recruiting The North-West Inter Regional Female Cohort for Patients With Endometriosis
Condition: Endometriosis
Intervention: Procedure: various surgical procedures in endometriosis
7 Completed Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
Condition: Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions: Drug: D-Cycloserine;   Drug: Placebo (for D-cycloserine)
8 Not yet recruiting Urinary and Anorectal Functional Disorders and Their Impact on CF Adults (PerineoMucoRMO)
Condition: Cystic Fibrosis
9 Completed Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Bladder Cancer;   Breast Cancer;   Colorectal Cancer;   Kidney Cancer;   Lung Cancer;   Pancreatic Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: irinotecan hydrochloride
10 Terminated
Has Results
Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Dietary Supplement: Arm A: Vitamin D3 Group;   Dietary Supplement: Placebo
11 Completed Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Procedure: conventional surgery;   Radiation: radiation therapy
12 Recruiting S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Methotrexate;   Drug: Vinblastine;   Drug: Doxorubicin;   Drug: Filgrastim
13 Unknown  Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: valrubicin;   Procedure: conventional surgery
14 Recruiting Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Prospective Observational Cohort Study Protocol
Condition: Lower Urinary Tract Symptoms
Interventions: Other: None-observational;   Procedure: Magnetic Resonance Imaging (MRI);   Other: Multimodal Automated Sensory Testing System;   Other: Auditory Sensitivity Test
15 Completed Combination Chemotherapy in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride
16 Terminated
Has Results
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
Conditions: Bladder Neoplasm;   Neoplasm Recurrence, Local;   Transitional Cell, Carcinoma;   Carcinoma in Situ;   Mycobacterium
Interventions: Biological: EN3348;   Biological: Mitomycin C
17 Completed Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter
Intervention: Drug: oxaliplatin
18 Recruiting Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
Condition: Solid Tumors
Interventions: Drug: NC-6004;   Drug: Gemcitabine
19 Completed S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Other: placebo
20 Completed Eflornithine in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: eflornithine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.